Citi Downgrades R1 RCM Inc (RCM) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/10/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- S&P Downgrades Oracle To 'bbb-/A-3'; Outlook Stable
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Citi names top picks in software ahead of Q2 earnings
RCM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of R1 RCM to TowerBrook Capital Partners and Clayton, Dubilier & Rice
August 1, 2024 4:57 PM EDTMONSEY, N.Y., Aug. 01, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the sale of R1 RCM, Inc. (Nasdaq: RCM) (RCM) for $14.30 per share in cash to TowerBrook Capital Partners (TowerBrook) and Clayton, Dubilier & Rice (CDR). The sales price is below the price targets for RCM of virtually every Wall Street analyst (source: TipRanks).
If you remain an RCM shareholder and question the fairness of the price, you may contact our firm at the following link to discuss your legal rights at no... More
RCM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of R1 RCM to TowerBrook Capital Partners and Clayton, Dubilier & Rice
August 1, 2024 4:56 PM EDTMONSEY, N.Y., Aug. 01, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the sale of R1 RCM, Inc. (Nasdaq: RCM) (RCM) for $14.30 per share in cash to TowerBrook Capital Partners (TowerBrook) and Clayton, Dubilier & Rice (CDR). The sales price is below the price targets for RCM of virtually every Wall Street analyst (source: TipRanks).
If you remain an RCM shareholder and question the fairness of the price, you may contact our firm at the following link to discuss your legal rights at no... More
